Yes, vape is substantially better than smoking per overwhelming UK and international evidence. UK Public Health England (now OHID) concluded vape is approximately 95% safer than smoking in 2015, a figure endorsed by Royal College of Physicians 2024 evidence review, King’s College London 2022 study, and NHS Better Health guidance. Cochrane systematic reviews (gold standard medical evidence) consistently show vape is more effective than NRT (patches, gum, lozenges) for smoking cessation – approximately twice as effective. ASH 2024 data: nearly 3 million UK smokers have successfully quit using vape over the past 5 years.

Why vape is so much better than smoking: it removes the combustion. Smoking burns tobacco at ~900°C, producing thousands of chemical compounds via pyrolysis: tar (carcinogenic), carbon monoxide (cardiovascular toxin), polycyclic aromatic hydrocarbons (Group 1 carcinogens), formaldehyde, benzene, hydrogen cyanide, and dozens more. These cause virtually all the cardiovascular disease, cancer and COPD attributable to smoking. Vape heats e-liquid at ~150-250°C, producing far fewer compounds. Tar is absent. Carbon monoxide is absent. Polycyclic aromatic hydrocarbons are absent or vastly reduced. Volatile organic compounds dramatically reduced. The biomarker evidence is striking: King’s College 2022 review found vapers who completely switched from smoking show dramatically reduced levels of all major smoking-related toxicants.

Why vape works better than NRT for smoking cessation: it mimics the experience of smoking more closely. Cigarettes deliver nicotine to the brain in 7-10 seconds via inhalation. Patches deliver nicotine over hours. Gum and lozenges over 20-30 minutes. Vape delivers nicotine in 7-10 seconds via inhalation – matching the speed and ritual that smokers find satisfying. Plus the hand-to-mouth action, throat hit, and exhaled “smoke-like” vapour. This combination of pharmacological similarity (rapid nicotine) and behavioural similarity (ritual) makes vape an effective transition tool. Cochrane Database of Systematic Reviews 2025 (most recent update): nicotine vape is more effective than NRT for smoking cessation. UK NHS now endorses vape as smoking cessation aid; many UK NHS Stop Smoking Services offer free vape starter packs as part of the government’s “Swap to Stop” scheme aiming to provide 1 million vapes to UK smokers.

What removing combustion actually means for your health

Specific harm-reduction details. Cancer risk: tobacco smoke is IARC Group 1 carcinogen, causing approximately 16 different cancers per Cancer Research UK. Vape vapour contains some Group 1 carcinogens (formaldehyde, acetaldehyde) but at substantially lower levels. Cancer Research UK: “There is no good evidence that vaping causes cancer” though risk for never-smokers is unknown long-term. Lung disease: smoking causes COPD (chronic obstructive pulmonary disease) through tar and carbon monoxide damage to alveoli and airways. Vape causes some airway irritation and small increases in airway resistance but does not produce the cumulative tissue destruction of smoking. UK research shows vapers who switched from smoking have improving lung function biomarkers over months to years. Cardiovascular disease: smoking doubles cardiovascular disease risk, doubles stroke risk, triples heart attack risk versus never-smokers. Vape has acute cardiovascular effects (heart rate, BP) but lacks carbon monoxide and most tar-related effects. The 2019 VESUVIUS study (Journal of the American College of Cardiology) showed switching from smoking to vape improves vascular function within 4 weeks. Reproductive health: smoking during pregnancy causes reduced fetal growth, premature birth, SIDS. Vape during pregnancy carries nicotine harms but eliminates carbon monoxide harm (carbon monoxide directly damages fetal oxygen supply). NHS pregnancy guidance: NRT > vape > continued smoking. Net effect across all major smoking diseases: vape carries small fraction of the disease burden.

The “Swap to Stop” UK scheme and free NHS vape starter packs

The UK government’s “Swap to Stop” scheme launched in 2023 as part of the smoke-free 2030 strategy, aiming to provide 1 million free vape starter packs to UK smokers. Implementation through NHS Stop Smoking Services in participating local authorities. Eligibility: current adult UK smokers wanting to quit. Process: contact NHS Stop Smoking, complete assessment, receive vape starter pack plus e-liquid plus behavioural support sessions. Free at point of use. UK areas with active Swap to Stop participation include parts of Greater London, Manchester, Birmingham, Liverpool, Glasgow, Cardiff and others. Combined with combination NRT, behavioural support and prescription medications, this gives UK smokers the most comprehensive cessation support package in any major economy. ASH 2024 outcome data: nearly 3 million UK smokers have quit using vape over past 5 years; vape is now the most popular UK stop smoking aid; almost two-thirds of UK smokers who use vape with NHS Stop Smoking support successfully quit smoking. For UK current smokers: this is the recommended pathway. Contact smokefree.nhs.uk or 0300 123 1044 to access local services. Free, no GP referral needed. Our Omagh and Strabane teams can advise on vape products suitable for transition from smoking, with the caveat that NHS Stop Smoking offers the cheapest pathway (free starter pack + behavioural support).

Limitations and caveats: why “better” does not mean “good for never-smokers”

Critical context for the “vape better than smoking” message. First, comparison context matters: vape is ~95% safer than smoking, meaning it has 5% of smoking’s health harms. That residual 5% is still meaningful absolute risk. Vape is “better than smoking” but not “safe.” Second, long-term effects unknown: vape has been mass-market only since ~2010. Cancer and lung disease from smoking became clear after 20-30 years. Vape research will continue maturing through the 2030s. Royal College of Physicians 2024: “possible elevation in long-term disease risk.” Third, dependence persistence: switching from smoking to vape maintains nicotine dependence. Many UK ex-smokers continue vaping indefinitely. NICE position: this is acceptable if it prevents smoking relapse. Fourth, gateway concerns: London School of Hygiene & Tropical Medicine 2025 review found teenagers who start vaping are around 3x more likely to subsequently smoke tobacco. UK youth vaping is a public health concern (7% of 11-17 year olds in 2025 ASH survey). Fifth, never-smoker calculation: for never-smokers, vape introduces small but non-zero health risk and clinical dependence for no benefit. UK Chief Medical Officer position: “if you smoke, vaping is much safer; if you do not smoke, do not vape.” The “better than smoking” message applies only to current smokers; it does not endorse vape for never-smokers, adolescents, or anyone outside the smoking cessation use case.

For UK smokers wanting to switch, the four-step NHS-standard protocol below maximises quit success.

For UK adults transitioning from smoking, the evidence is overwhelmingly positive: vape is ~95% safer than smoking, nearly twice as effective as NRT for quit success, and supported by free NHS services. The “Swap to Stop” scheme makes vape financially accessible. For UK never-smokers: vape is not recommended despite being safer than smoking – the comparison only applies if you are already smoking. Our Omagh and Strabane teams stock TPD-compliant pod systems and refillable devices suitable for smokers transitioning to vape, with guidance on nicotine strengths for cigarette equivalence.